Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma

Human Pathology

Volumn 37, Issue 10, 2006, Pages 1350-1356

  Zhang, Peng ^a   Zhang, Cunxian ^a   Hao, Jie ^a   Sung, C James ^a   Quddus, M Ruhul ^a   Steinhoff, Margaret M ^a   Lawrence, W Dwayne ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Clonality; Leiomyoma; Leiomyosarcoma; X chromosome inactivation

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MOLECULAR CLONING; MORPHOLOGY; NEOPLASM; UTERUS MYOMA; UTERUS TUMOR; X CHROMOSOME INACTIVATION;

ADULT; CHROMOSOMES, HUMAN, X; CLONE CELLS; DNA, NEOPLASM; FEMALE; HUMANS; LEIOMYOMA; LEIOMYOSARCOMA; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, ANDROGEN; UTERINE NEOPLASMS; X CHROMOSOME INACTIVATION;

EID: 33748610260     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.05.005     Document Type: Article

References (24)

1. Zaloudek C., and Hendrickson MR. Mesenchymal tumors of the uterus. In: Kurman R.J. (Ed). Blausteins's pathology of the female genital tract. 5th ed (2002), Springer, New York 561-615
2. Lee W.Y., Tzeng C.C., and Chou C.Y. Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist. Gynecol Oncol 52 (1994) 74-79
3. Lee J.M., Baumgartner F.J., Shellans S., Butler J., and French S. Degeneration and sarcomatous transformation of a retroperitoneal leiomyoma. Eur J Surg 162 (1996) 337-340
4. Jatoi N. Leiomyosarcoma: a rare malignant change in a leiomyoma. J Coll Physicians Surg Pak 13 (2003) 106-107
5. Persaud V., and Arjoon P.D. Uterine leiomyoma. Incidence of degenerative change and a correlation of associated symptoms. Obstet Gynecol 35 (1970) 432-436
6. Fialkow P.J. Clonal origin of human tumors. Biochim Biophys Acta 458 (1976) 283-321
7. Allen R.C., Zoghbi H.Y., Moseley A.B., Rosenblatt H.M., and Belmont J.W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51 (1992) 1229-1239
8. van Kamp H., Jansen R., Willemze R., Fibbe W.E., and Landergent J.E. Studies on clonality by PCR analysis of the PGK-1 gene. Nucleic Acids Res 19 (1991) 2794
9. Vogelstein B., Fearon E.R., Hamilton S.R., and Feinberg A.P. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 227 (1985) 642-645
10. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 47 (1987) 4806-4813
11. Lyon MF. Gene action in the X-chromosome of the mouse. Nature 190 (1961) 372-373
12. Lyon M.F. X-chromosome inactivation and developmental patterns in mammals. Biol Rev Camb Philos Soc 47 (1972) 1-35
13. Hashimoto K., Azuma C., Kamiura S., et al. Clonal determination of uterine leiomyomas by analyzing differential invactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest 40 (1995) 204-208
14. Wang S., Su Q., Zhu S., Liu J., Hu L., and Li D. Clonality of multiple uterine leiomyomas. Zhonghua Bing Li Xue Za Zhi 31 (2002) 107-111
15. Linder D., and Gartler S.M. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science 150 (1965) 67-69
16. Townsend D.E., Sparkes R.S., Baluda M.C., and McClelland G. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 107 (1970) 1168-1173
17. Mashal R.D., Fejzo M.L., Friedman A.J., et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 11 (1994) 1-6
18. Baschinsky D.Y., Isa A., Niemann T.H., Prior T.W., Lucas J.G., and Frankel WL. Diffuse leiomyomatosis of the uterus: a case report with clonality analysis. Hum Path 31 (2000) 1429-1432
19. Fujimoto J., Hirose R., Sakaguchi H., and Tamaya T. Expression of size-polymorphic androgen receptor gene in uterine leiomyoma according to the number of cytosine, adenine, and guanine repeats in androgen receptor alleles. Tumour Biol 21 (2000) 33-37
20. Taylor H.B., and Norris H.J. Mesenchymal tumors of the uterus. IV. Diagnosis and prognosis of leiomyosarcomas. Arch Pathol 82 (1966) 40-44
21. Schwartz S.M., Weiss N.S., Daling J.R., et al. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus. Cancer 77 (1996) 717-724
22. Bodner K., Bodner-Adler B., Kimberger O., Czerwenka K., Leodolter S., and Mayerhofer K. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters. Anticancer Res 23 (2003) 729-732
23. Kelley T.W., Borden E.C., and Goldblum J.R. Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study. Appl Immunohistochem Molecul Morphol 12 (2004) 338-341
24. Ranchod M., and Kempson R.L. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: a pathologic analysis of 100 cases. Cancer 39 (1977) 255-262